Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Male contraceptive - Schering AG/Organon

Drug Profile

Male contraceptive - Schering AG/Organon

Alternative Names: Etonogestrel/testosterone undecanoate; Male Pill - Schering/Organon; ORG 3236 plus testosterone undecanoate; Testosterone undecanoate/etonogestrel

Latest Information Update: 13 Nov 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer Schering Pharma; Organon
  • Class
  • Mechanism of Action Progesterone receptor agonists; Testosterone agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Pregnancy

Most Recent Events

  • 13 Nov 2006 Discontinued - Phase-II for Pregnancy (Prevention)/Male contraception in Europe (Intradermal)
  • 23 Jan 2004 Schering and Organon has initiated enrolment in a phase II trial for Pregnancy (Prevention)/Male Contraception in 14 centres throughout Europe
  • 21 Nov 2002 Phase-II clinical trials in Pregnancy (Prevention)/Male contraception in Europe (Intradermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top